Is Medicinova Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: MNOV) stock is to Strong Buy MNOV stock.
Out of 1 analyst, 1 (100%) are recommending MNOV as a Strong Buy, 0 (0%) are recommending MNOV as a Buy, 0 (0%) are recommending MNOV as a Hold, 0 (0%) are recommending MNOV as a Sell, and 0 (0%) are recommending MNOV as a Strong Sell.
What is MNOV's forecast return on equity (ROE) for 2025-2026?
(NASDAQ: MNOV) forecast ROE is -22.42%, which is considered weak.
What is MNOV's Price Target?
According to 1 Wall Street analyst that have issued a 1 year MNOV price target, the average MNOV price target is $9.00, with the highest MNOV stock price forecast at $9.00 and the lowest MNOV stock price forecast at $9.00.
The Wall Street analyst predicted that Medicinova's share price could reach $9.00 by Apr 9, 2026. The average Medicinova stock price prediction forecasts a potential upside of 492.11% from the current MNOV share price of $1.52.
What is MNOV's forecast return on assets (ROA) for 2025-2026?
(NASDAQ: MNOV) forecast ROA is -21.07%, which is lower than the forecast US Biotechnology industry average of 932.61%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.